MedPath

A clinical study to see the effect of Viola Odorata(homoeopathic medicine) in treatment of Chronic Bronchitis

Phase 3
Completed
Conditions
Health Condition 1: J42- Unspecified chronic bronchitis
Registration Number
CTRI/2023/02/049490
Lead Sponsor
Dr Ruchita Jerath
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Those cases fulfilling the CBSS criteria and suffering is since 2 years or more.

2. Patients of All sexes will be included in the study.

3. Patients of 18 to 40 years age groups of various socio-economic groups will be included.

4. Patient without any other systemic diseases.

5. Patient giving written consent form.

6. Patients coming under the case definition according to CBSS will be included.

Exclusion Criteria

1. That doesn’t fulfill CBSS criteria.

2. Cases with serious complication of Respiratory system and/or recently taking strong steroidal medication and having acute exacerbation of bronchitis.

3. Patients with Psychiatric diagnosis.

4. Pregnant and lactating women.

5. Malignancy cases.

6. Recent major surgery.

7. Immuno compromised cases.

8. Patients who have participated in any other Research study in last 6 months

9.Those under other medications for other diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To check the effectiveness of Viola Odorata in cases of Chronic Bronchiti using chronic bronchitis severity scale at day 1 and at every follow up.Timepoint: Improvement according to chronic bronchitis severity scale at day 1 and again after <br/ ><br>every 15 days, for the total of 12 weeks will be assessed in every case to see the effect of viola odorata.
Secondary Outcome Measures
NameTimeMethod
To give the maximum relief of symptoms of the patient by following up at every 7 days and to minimize the frequency of symptom of cough and wheezing in patient using CAT assessment.Timepoint: CAT assessment used at day 1 and at every 7 days so assess the frequency of symptoms of cough and wheezing patients within 12 weeks of duration.
© Copyright 2025. All Rights Reserved by MedPath